Skip to Main Content

Paper Details

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.
Diabetes Care
9
2022
Bladder Cancer, DPP-4, GLP, GLP-1RA, GLP-1RAs, Glucose, SGLT2, Sodium-, Sodium-Glucose Cotransporter 2, bladder cancer, dipeptidyl peptidase 4, glucagon-like peptide 1 receptor, glucose, sodium-, sodium-glucose cotransporter 2, type 2 diabetes
Author NameAffiliation
Seanna VineDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Elisabetta PatornoDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2